Home Applications 205834 Application 205834
Type NDA
Sponsor GILEAD SCIENCES INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 HARVONI LEDIPASVIR; SOFOSBUVIR TABLET;ORAL 90MG;400MG Yes Yes 002 HARVONI LEDIPASVIR; SOFOSBUVIR TABLET;ORAL 45MG;200MG Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N205834-001 HARVONI LEDIPASVIR; SOFOSBUVIR 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 N205834-002 HARVONI LEDIPASVIR; SOFOSBUVIR 45MG;200MG TABLET / ORAL RLD 2019-08-28
Orange Book patents# Current patent rows page 1 of 1 · 67 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N205834-001 8334270 2028-03-21 U-1470 Drug substance, Drug product 2014-10-30 N205834-001 8580765 2028-03-21 U-1470 Drug substance, Drug product 2014-10-30 N205834-001 8735372 2028-03-21 U-1470 2014-10-30 N205834-001 9085573 2028-03-21 U-1470 Drug substance, Drug product 2015-08-11 N205834-001 8334270*PED 2028-09-21 Pediatric extension N205834-001 8580765*PED 2028-09-21 Pediatric extension N205834-001 8735372*PED 2028-09-21 Pediatric extension N205834-001 9085573*PED 2028-09-21 Pediatric extension N205834-001 7964580 2029-03-26 U-1470 Drug substance, Drug product 2014-10-30 N205834-001 8633309 2029-03-26 U-1470 Drug substance, Drug product 2014-10-30 N205834-001 8889159 2029-03-26 U-1470 Drug product 2014-12-11 N205834-001 7964580*PED 2029-09-26 Pediatric extension N205834-001 8633309*PED 2029-09-26 Pediatric extension N205834-001 8889159*PED 2029-09-26 Pediatric extension N205834-001 8088368 2030-05-12 Drug substance, Drug product 2014-10-30 N205834-001 8273341 2030-05-12 U-1470 2014-10-30 N205834-001 8822430 2030-05-12 U-1470 Drug substance, Drug product 2014-10-30 N205834-001 8841278 2030-05-12 U-1470 Drug product 2014-10-30 N205834-001 9511056 2030-05-12 U-1470 Drug product 2017-01-05 N205834-001 9284342 2030-09-13 U-1470 Drug substance, Drug product 2016-04-12 N205834-001 8088368*PED 2030-11-12 Pediatric extension N205834-001 8273341*PED 2030-11-12 Pediatric extension N205834-001 8822430*PED 2030-11-12 Pediatric extension N205834-001 8841278*PED 2030-11-12 Pediatric extension N205834-001 9511056*PED 2030-11-12 Pediatric extension N205834-001 8618076 2030-12-11 U-1470 Drug substance, Drug product 2014-10-30 N205834-001 9284342*PED 2031-03-13 Pediatric extension N205834-001 8618076*PED 2031-06-11 Pediatric extension N205834-001 10456414 2032-09-14 Drug product 2019-11-20 N205834-001 9393256 2032-09-14 U-1470 2016-08-15 N205834-001 9393256*PED 2033-03-14 Pediatric extension N205834-001 10039779 2034-01-30 U-2369 Drug substance, Drug product 2018-08-29 N205834-001 10039779 2034-01-30 U-2370 Drug substance, Drug product 2018-08-29 N205834-001 10039779*PED 2034-07-30 Pediatric extension N205834-002 8334270 2028-03-21 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 8580765 2028-03-21 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 8735372 2028-03-21 U-1470 2019-09-23 N205834-002 9085573 2028-03-21 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 8334270*PED 2028-09-21 Pediatric extension N205834-002 8580765*PED 2028-09-21 Pediatric extension N205834-002 8735372*PED 2028-09-21 Pediatric extension N205834-002 9085573*PED 2028-09-21 Pediatric extension N205834-002 7964580 2029-03-26 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 8633309 2029-03-26 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 8889159 2029-03-26 U-1470 Drug product 2019-09-23 N205834-002 7964580*PED 2029-09-26 Pediatric extension N205834-002 8633309*PED 2029-09-26 Pediatric extension N205834-002 8889159*PED 2029-09-26 Pediatric extension N205834-002 8088368 2030-05-12 Drug substance, Drug product 2019-09-23 N205834-002 8273341 2030-05-12 U-1470 2019-09-23 N205834-002 8822430 2030-05-12 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 8841278 2030-05-12 U-1470 Drug product 2019-09-23 N205834-002 9511056 2030-05-12 U-1470 2019-09-23 N205834-002 9284342 2030-09-13 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 8088368*PED 2030-11-12 Pediatric extension N205834-002 8273341*PED 2030-11-12 Pediatric extension N205834-002 8822430*PED 2030-11-12 Pediatric extension N205834-002 8841278*PED 2030-11-12 Pediatric extension N205834-002 9511056*PED 2030-11-12 Pediatric extension N205834-002 8618076 2030-12-11 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 9284342*PED 2031-03-13 Pediatric extension N205834-002 8618076*PED 2031-06-11 Pediatric extension N205834-002 10456414 2032-09-14 Drug product 2019-11-20 N205834-002 9393256 2032-09-14 U-1470 2019-09-23 N205834-002 9393256*PED 2033-03-14 Pediatric extension N205834-002 10039779 2034-01-30 U-1470 Drug substance, Drug product 2019-09-23 N205834-002 10039779*PED 2034-07-30 Pediatric extension
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 2 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N205834-001 ODE* 2026-08-28 N205834-002 ODE* 2026-08-28
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 81 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 4b0b4de00fa7…2022-04-04 05:41 UTC 2022-04 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 74a2ff9319b5…2019-12-13 00:20 UTC 2019-12 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 bb7c543d1eb4…2022-03-09 01:35 UTC 2022-03 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N205834-001 HARVONI 90MG;400MG TABLET / ORAL RLD, RS 2014-10-10 782e0a99824c…2021-12-28 21:50 UTC 2021-12 N205834-002 HARVONI 45MG;200MG TABLET / ORAL RLD 2019-08-28 782e0a99824c…
Observed Orange Book patent history# Patent history page 1 of 67 · 2,661 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N205834-001 8334270 2028-03-21 U-1470 Drug substance, Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8580765 2028-03-21 U-1470 Drug substance, Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8735372 2028-03-21 U-1470 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9085573 2028-03-21 U-1470 Drug substance, Drug product 2015-08-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8334270*PED 2028-09-21 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8580765*PED 2028-09-21 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8735372*PED 2028-09-21 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9085573*PED 2028-09-21 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 7964580 2029-03-26 U-1470 Drug substance, Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8633309 2029-03-26 U-1470 Drug substance, Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8889159 2029-03-26 U-1470 Drug product 2014-12-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 7964580*PED 2029-09-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8633309*PED 2029-09-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8889159*PED 2029-09-26 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8088368 2030-05-12 Drug substance, Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8273341 2030-05-12 U-1470 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8822430 2030-05-12 U-1470 Drug substance, Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8841278 2030-05-12 U-1470 Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9511056 2030-05-12 U-1470 Drug product 2017-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9284342 2030-09-13 U-1470 Drug substance, Drug product 2016-04-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8088368*PED 2030-11-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8273341*PED 2030-11-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8822430*PED 2030-11-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8841278*PED 2030-11-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9511056*PED 2030-11-12 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8618076 2030-12-11 U-1470 Drug substance, Drug product 2014-10-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9284342*PED 2031-03-13 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 8618076*PED 2031-06-11 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 10456414 2032-09-14 Drug product 2019-11-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9393256 2032-09-14 U-1470 2016-08-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 9393256*PED 2033-03-14 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 10039779 2034-01-30 U-2369 Drug substance, Drug product 2018-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 10039779 2034-01-30 U-2370 Drug substance, Drug product 2018-08-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-001 10039779*PED 2034-07-30 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-002 8334270 2028-03-21 U-1470 Drug substance, Drug product 2019-09-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-002 8580765 2028-03-21 U-1470 Drug substance, Drug product 2019-09-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-002 8735372 2028-03-21 U-1470 2019-09-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-002 9085573 2028-03-21 U-1470 Drug substance, Drug product 2019-09-23 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-002 8334270*PED 2028-09-21 Pediatric extension 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N205834-002 8580765*PED 2028-09-21 Pediatric extension 011fe1cb6892…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 7 · 279 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 18 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 61958-1801 Harvoni LEDIPASVIR and SOFOSBUVIR Gilead Sciences, Inc NDA Current 61958-1801 Harvoni LEDIPASVIR and SOFOSBUVIR Gilead Sciences, Inc NDA Current 61958-1801 Harvoni LEDIPASVIR and SOFOSBUVIR Gilead Sciences, Inc NDA Current 61958-1801 Harvoni LEDIPASVIR and SOFOSBUVIR Gilead Sciences, Inc NDA Current 61958-1801 Harvoni LEDIPASVIR and SOFOSBUVIR Gilead Sciences, Inc NDA Current 61958-1801 Harvoni LEDIPASVIR and SOFOSBUVIR Gilead Sciences, Inc NDA Current 61958-1801 Harvoni LEDIPASVIR and SOFOSBUVIR Gilead Sciences, Inc NDA Current 61958-1803 Harvoni ledipasvir and sofosbuvir Gilead Sciences, Inc NDA Current 61958-1803 Harvoni ledipasvir and sofosbuvir Gilead Sciences, Inc NDA Current 61958-1803 Harvoni ledipasvir and sofosbuvir Gilead Sciences, Inc NDA Current 61958-1803 Harvoni ledipasvir and sofosbuvir Gilead Sciences, Inc NDA Current 61958-1803 Harvoni ledipasvir and sofosbuvir Gilead Sciences, Inc NDA Current 61958-1803 Harvoni ledipasvir and sofosbuvir Gilead Sciences, Inc NDA Current 72626-2601 Ledipasvir and Sofosbuvir Ledipasvir and Sofosbuvir Asegua Therapeutics LLC NDA AUTHORIZED GENERIC Current 72626-2601 Ledipasvir and Sofosbuvir Ledipasvir and Sofosbuvir Asegua Therapeutics LLC NDA AUTHORIZED GENERIC Current 72626-2601 Ledipasvir and Sofosbuvir Ledipasvir and Sofosbuvir Asegua Therapeutics LLC NDA AUTHORIZED GENERIC Current 72626-2601 Ledipasvir and Sofosbuvir Ledipasvir and Sofosbuvir Asegua Therapeutics LLC NDA AUTHORIZED GENERIC Current 72626-2601 Ledipasvir and Sofosbuvir Ledipasvir and Sofosbuvir Asegua Therapeutics LLC NDA AUTHORIZED GENERIC Current